1.Progress of Th17 cells in chronic rhinosinusitis.
Yang WANG ; Zhenzhen TANG ; Dongfang YAO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2016;30(2):161-166
Chronic rhinosinusitis is a common disease and frequently encountered disease in otolaryngology, but the therapeutic effect is not ideal. While its pathogenesis is exploring in the continuously. Found in the recent years, Th17 cells are a new subset of T cells and closely related with inflammatory disorders, autoimmune diseases and cancer. Its differentiation, regulation and biological effects are widely noted as a hot area of research. This review explores the discovery of differentiation and regulation of Th17 cells, the relationship between related cytokines and chronic rhinosinusitis, in order to have a beteer knowledge of chronic rhinosinusitis. This review regards Th17 cells as the main clue, nevertheless, lacking consideration of the impacts of other factors on chronic rhinosinusitis.
Chronic Disease
;
Humans
;
Rhinitis
;
immunology
;
Sinusitis
;
immunology
;
Th17 Cells
;
immunology
2.The role of Th17 cells in liver diseases.
Ye ZHANG ; Chang-xing HUANG ; Jiu-ping WANG ; Jian-qi LIAN ; Xue-fan BAI
Chinese Journal of Hepatology 2012;20(4):316-318
3.Immunoregulatory effects of interleukin-17 and Th17 cells in graft-versus-host disease.
Journal of Experimental Hematology 2014;22(3):861-864
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an intensive therapy to cure high-risk haematological malignant disorders, congenital diseases, autoimmune disease and so on. The main complication of HSCT is graft-versus-host disease (GVHD), which can cause the death of recipients and affect the therapeutic effect. Many kinds of immune cells and inflammatory factors were involved in the occurrence of GVHD. Twenty years ago the mice and human interleukin-17 (IL-17) were found. A new kind of T cell-CD4(+) IL-17(+) T was found in recent years, named Th17 cells. Now IL-17 and Th17 cells have become the hot spot in the research field of infection immunity, autoimmune diseases, tumor immunity and GVHD. In this article, immunoregulatory effects of interleukin-17 and Th17 cells in GVHD are reviewed.
Animals
;
Graft vs Host Disease
;
immunology
;
therapy
;
Humans
;
Immunomodulation
;
Interleukin-17
;
immunology
;
Mice
;
Th17 Cells
;
immunology
4.Recent progress of study on imbalance of Th17/Treg cells in aplastic anemia.
You-Wei YANG ; Zhi-Yin ZHENG ; Hong-Zhang YAO
Journal of Experimental Hematology 2012;20(1):214-218
Aplastic anemia (AA) is an autoimmune disease characterized by destruction of hematopoietic tissue resulting in hyperfunction of effector T-lymphocytes. Recent studies indicate that Th17 and Treg cells are functionally antagonistic each other, and the increase of Th17 cells and decrease of Treg cells are closely related with AA. In vivo experiments showed that both anti-IL-17 treatment and Treg cell infusion can protect against immune-mediated bone marrow failure in mouse with AA. This review summarizes the recent progress of study on imbalance of Th17/Treg cells in AA, so as to explore the pathogenesis of AA and provide approach to clinical treatment. The main problems that are discussed in this review include biological characteristics of Th17/Treg cells, the regulation of Th17/Treg cell balance and related cytokines, the relationship between Th17/Treg cells and AA.
Anemia, Aplastic
;
immunology
;
pathology
;
Humans
;
T-Lymphocytes, Regulatory
;
immunology
;
Th17 Cells
;
immunology
5.Measurement of myeloid-derived suppressor cells and T-helper 17 cells in peripheral blood of young children with recurrent wheezing.
Pan WANG ; Jian-Ping LV ; Jin-Quan LV
Chinese Journal of Contemporary Pediatrics 2015;17(4):312-316
OBJECTIVETo determine the frequencies and significance of myeloid-derived suppressor cells (MDSCs) and T-helper 17 (Th17) cells in peripheral blood of young children with recurrent wheezing.
METHODSThirty young children with an acute exacerbation of recurrent wheezing were randomly enrolled. Twenty age-matched children with bronchopneumonia (pneumonia group) and 23 age-matched preoperative children with non-infectious or non-neoplastic diseases (hernia or renal calculus) (control group) were selected. The frequencies of MDSCs and Th17 cells in the peripheral blood were measured using flow cytometry and their correlation was determined by the Spearman's correlation coefficient.
RESULTSThe percentage of MDSCs in nucleated cells was significantly higher in the wheezing group than in the pneumonia and control groups (P<0.05), and it was significantly higher in the pneumonia group than in the control group (P<0.05). The percentage of Th17 cells in mononuclear cells was significantly higher in the wheezing group than in the pneumonia and control groups (P<0.05), but it showed no significant difference between the pneumonia and control groups (P>0.05). The frequency of MDSCs was positively correlated with the frequency of Th17 cells in the wheezing group (r=0.645, P<0.01).
CONCLUSIONSMDSCs and Th17 cells may contribute to the pathogenesis of recurrent wheezing in young children.
Child, Preschool ; Female ; Humans ; Infant ; Leukocytes, Mononuclear ; immunology ; Male ; Myeloid Cells ; immunology ; Recurrence ; Respiratory Sounds ; immunology ; Th17 Cells ; immunology
6.Th17 cells and aplastic anemia.
Hai-Yan ZHANG ; Wu WEI ; Xu-Liang SHEN
Journal of Experimental Hematology 2014;22(5):1463-1466
During the past few years, a novel family of CD4⁺T cell lineage was detected and named as Th17 cells because of its unique ability expressing IL-17, which also can produce IL-17A, IL-17F, IL-21, IL-22 and IL-26. Some cytokines, such as TGF-β, IL-6, L-23 may promote the differentiation of Th17 subset, whereas some cytokines, such as IL-21, IL-2, IFN-γ, may have inhibitory effects. Th17 cells serving as immune effectors play an important role in autoimmune diseases caused by chronic inflammation injury. More and more studies confirmed that Th17 cells have closely correlations with the development of aplastic anemia, and may be a new target in the diagnosis, therapy, prognosis and prophylaxis of aplastic anemia.
Anemia, Aplastic
;
immunology
;
Autoimmune Diseases
;
Cell Differentiation
;
Cytokines
;
Humans
;
Inflammation
;
Th17 Cells
;
cytology
;
immunology
7.The role of Th17 cells in immune thrombocytopenia mice models.
Ting-ting WANG ; Hui-yuan LI ; Zhao WANG ; Ze-ping ZHOU ; Li FU ; Na WEI ; Da-yong HUANG ; Ren-chi YANG
Chinese Journal of Hematology 2011;32(9):592-596
OBJECTIVETo investigate the role of Th17 cells in immune thrombocytopenia (ITP) mice model.
METHODITP was induced by daily intraperitoneal injection of anti-platelet membrane CD41 antibody (MWReg30) into BALB/c mice, the mRNA expressions of Th17 cell associated transcription factors and cytokines in peripheral blood and spleen mononuclear cells were measured by real-time PCR, and the proportion of Th17 cells by FCM analysis.
RESULTSThe percentage of Th17 cell was significantly elevated in ITP mice both in splenocyte and peripheral blood as compared with that in normal controls (P<0.01). ITP mice had elevated mRNA expressions of IL-17F, IL-17A and IL-6 in splenocyte (P<0.05), and of IL-21 in peripheral blood (P<0.05). There was a positive correlation between IL-17A and IL-17F (r = 0.934, P = 0.000), and between IL-17A/IL-17F and IL-6 (r = 0.598, P = 0.001; r = 0. 619, P = 0.000).
CONCLUSIONSTh17 cell might play an important role in the pathogenesis of ITP, at least involving in the clearance of platelets.
Animals ; Disease Models, Animal ; Female ; Mice ; Mice, Inbred BALB C ; Th17 Cells ; immunology ; Thrombocytopenia ; immunology
9.Imbalance of treg/th17 in bone marrow of patients with multiple myeloma.
Jian XING ; Guang LU ; Guo-Qiang LIU ; Min XU ; Xia ZHAO ; Fang HAN ; Liang WANG ; Hui-Fang DING
Journal of Experimental Hematology 2014;22(5):1321-1325
The purpose of this study was to detect the distribution of Treg and Th17 cells in bone marrow and to investigate the relationship of Treg/Th17 imbalance with the pathogenesis and progression of multiple myeloma (MM). The Bone marrow was collected from 37 MM patients and 12 healthy volunteers, the ratio of Treg and Th17 cells was detected by flow cytometry. The expression of Treg and Th17 cells simultaneously was examined in peripheral blood of 19 MM patients with same method. The results indicated that the frequency of Treg cells was higher in MM patients than that in control group (P < 0.05), there was a trend of increasing of Treg cell number in the ISS stage from I+II to III (P < 0.05). Furthermore, in the patients with MM, the Treg cell number in bone marrow was higher than that in peripheral blood (P < 0.05). Th17 cell rate was not statistically different between MM patients and control group (P > 0.05), and at different ISS stage (P > 0.05). Th17 cell number between bone marrow and peripheral blood was not significantly different (P > 0.05).The ratio of Treg/Th17 in patients with MM was higher than that in control group (P < 0.05), and increased gradually from ISS stage I+II to stage III (P < 0.05). It is concluded that the Treg/Th17 immune imbalance is presenced in bone marrow of patients with MM, this imbalance may promote the progression of MM.
Bone Marrow
;
immunology
;
Cell Count
;
Disease Progression
;
Flow Cytometry
;
Humans
;
Multiple Myeloma
;
immunology
;
T-Lymphocytes, Regulatory
;
immunology
;
Th17 Cells
;
immunology
10.Immunoregulatory function of interleukin-6 on human Th17 cells.
Zhen-Xing GUO ; Cui-Ling ZHENG ; Zhen-Ping CHEN ; Wen-Chuan DONG ; Ren-Chi YANG
Journal of Experimental Hematology 2011;19(2):496-498
The aim of this study was to explore the regulatory function of interleukin-6(IL-6) on human Th17 cells. Human peripheral blood CD4(+) T cells were purified from healthy donors by anti-CD4 monoclonal antibody (mAb) conjugated microbeads. The experiment was divided into 2 groups. Test group in which CD4(+) T cells (1 × 10(6)/ml) were stimulated by human recombined IL-6 (20 ng/ml) for 4 days; control group in which CD4(+) T cells did not stimulated by IL-6. The concentrations of IL-17 protein in the supernatants were assayed by enzyme-linked immunosorbent assay (ELISA), and quantity of Th17 cells were detected by flow cytometry. The results showed that as compared to control group, IL-17 protein level in the supernatants of CD4(+) T cells significantly increased in IL-6 stimulated group: (337.05 ± 189.09 pg/ml; vs 15.07 ± 12.70 pg/ml) (p < 0.05). Furthermore, the percentage of Th17 cells in cultures of CD4(+) T cells stimulated by IL-6 was significantly higher than that in control group (4.05% ± 0.30% vs. 2.81% ± 0.44%)(p < 0.01). It is concluded that IL-6 promotes the expansion of Th17 cells in vitro.
CD4-Positive T-Lymphocytes
;
cytology
;
immunology
;
Cells, Cultured
;
Humans
;
Interleukin-6
;
pharmacology
;
Lymphocyte Activation
;
immunology
;
Th17 Cells
;
drug effects
;
immunology